@prefix prodottidellaricerca: . @prefix istituto: . @prefix prodotto: . istituto:CDS045 prodottidellaricerca:prodotto prodotto:ID64226 . @prefix pubblicazioni: . @prefix unitaDiPersonaleInterno: . unitaDiPersonaleInterno:MATRICOLA6729 pubblicazioni:autoreCNRDi prodotto:ID64226 . @prefix modulo: . modulo:ID2507 prodottidellaricerca:prodotto prodotto:ID64226 . @prefix rdf: . @prefix retescientifica: . prodotto:ID64226 rdf:type retescientifica:ProdottoDellaRicerca , prodotto:TIPO1101 . @prefix rdfs: . prodotto:ID64226 rdfs:label "Advances in the development of devices for noninvasive glycemia monitoring: who will win the race? (Articolo in rivista)"@en . @prefix xsd: . prodotto:ID64226 pubblicazioni:anno "2010-01-01T00:00:00+01:00"^^xsd:gYear . @prefix skos: . prodotto:ID64226 skos:altLabel "
Tura, A (2010)
Advances in the development of devices for noninvasive glycemia monitoring: who will win the race?
"^^rdf:HTML ; pubblicazioni:autori "Tura, A"^^xsd:string ; pubblicazioni:paginaInizio "33"^^xsd:string ; pubblicazioni:paginaFine "9"^^xsd:string ; pubblicazioni:numeroVolume "28"^^xsd:string ; pubblicazioni:titolo "Advances in the development of devices for noninvasive glycemia monitoring: who will win the race?"^^xsd:string ; prodottidellaricerca:abstract "The development of a reliable method for noninvasive glycemia monitoring would have\na tremendous medical and social impact for the management of diabetes, due to its high and\nincreasing prevalence. This is indeed a topic of great interest, and one that is rapidly evolving.\nSome noninvasive glucose meters that entered the European and/or US market in recent years are\ndescribed: Diasensor (based on near infrared spectroscopy), Pendra (based on impedance spectroscopy),\nand GlucoWatch (based on reverse iontophoresis). Unfortunately, none of these is currently\navailable on the market anymore. However, some promising new device prototypes (not on the\nmarket yet) have emerged in recent months: TANGTEST Blood Glucose Meter (based on an optical\ntechnology), RIGMD (based on reverse iontophoresis), Aprise (based on photoacoustic technology),\nand Sentris-100 (based on optical coherence tomography). In the clinical studies reported in the literature,\nthese prototypes generally showed good performance in terms of accuracy in glycemia measurement,\nwith agreement with traditional glucose measurement techniques of up to 99% (in terms of measurement\ndata pairs falling within Zone A and B of the Clarke error grid). Thus, though great efforts in\nresearch are still needed, the goal of noninvasive glycemia monitoring may be reached in a near future." ; prodottidellaricerca:prodottoDi modulo:ID2507 , istituto:CDS045 ; pubblicazioni:autoreCNR unitaDiPersonaleInterno:MATRICOLA6729 .